Compare NMAD & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMAD | GOSS |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.9M | 70.8M |
| IPO Year | 2020 | 2018 |
| Metric | NMAD | GOSS |
|---|---|---|
| Price | $2.40 | $11.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $83.40 |
| AVG Volume (30 Days) | ★ 260.9K | 159.4K |
| Earning Date | 11-16-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.75 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $200,000.00 | ★ $48,471,000.00 |
| Revenue This Year | N/A | $33.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.15 | $0.11 |
| 52 Week High | $6.40 | $12.52 |
| Indicator | NMAD | GOSS |
|---|---|---|
| Relative Strength Index (RSI) | 32.30 | 58.70 |
| Support Level | N/A | $0.18 |
| Resistance Level | $4.35 | $12.05 |
| Average True Range (ATR) | 0.49 | 1.08 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 11.30 | 72.24 |
Nomad Power Solutions Inc is a pioneering mobile, utility-grade truck-transportable battery energy storage system. The company's first-to-market products provide one megawatt of instantaneous power to an electrical grid or facility, bypassing months of construction typically required for traditional fixed installations. Its patented platforms, which are deployed on semi-trailers, serve emerging AI-driven applications, along with utilities, industrial operators, government agencies, and critical infrastructure providers through equipment sales, rentals and Energy-as-a-Service offerings. The group's products are Traveler, Voyager Eagle, Voyager Falcon, Voyager Hawk, and Compare Products. Its applications are Utilities, Peak Shaving, EV Charging, and Mining.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).